交易中 09-19 12:13:33 美东时间
+0.009
+1.86%
Oragenics shares are trading lower by 47% during Wednesday's session. The company announced a $4.45 million public offering.
09-05 00:22
转自:国家药监局网站 经国家药品监督管理局仿制药质量和疗效一致性评价专家委员会审核确定,现发布仿制药参比制剂目录(第八十二批)。 特此通告。 ...
08-30 15:23
Oragenics Inc: Phase 2 Human Trials of Onp-002 Are Being Planned With Anticipat...
08-17 04:32
Oragenics, Inc. Provides Update on Its Drug Intended to Treat Concussion and No...
08-17 04:30
• ONP-002 stability eliminates need for cumbersome cold storage• No FDA-approved pharmaceutical treatment available for concussion
08-14 20:34
Oragenics Inc. Shows Concussion Drug, Onp-002, Designed for Acute Field-Deliver...
08-14 20:31
Oragenics Inc - Onp-002 Stability Eliminates Need for Cumbersome Cold Storage
08-14 20:31
Oragenics, Inc. Announces Concussion Drug Successfully Completes FDA-Required G...
08-12 20:30